Fingolimod Completed Phase 1 Trials for Relapsing Remitting Multiple Sclerosis (RRMS)

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT02193217A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303